Magic Hour
You are here:  Home  >  Central Coast Health Watch  >  Current Article

MannKind burns through $23.3 million in cash

By   /   Tuesday, November 7th, 2017  /   Comments Off on MannKind burns through $23.3 million in cash

    Print       Email
MannKind Corp., a biotechnology company headquartered in Westlake Village, reported $1.98 million in product sales, resulting in $32.9 million in net losses for the quarter ended Sept. 30. The company, which manufactures an inhalable insulin product called Afrezza, reported a cash burn of $23.3 million, ending the quarter with slightly more than $20 million in…


    This article is only available to Business Times subscribers
  • Subscribers: or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.
    Print       Email

You might also like...

Carpinteria-based Procore Technologies moved up from No. 880 last year to No. 697 this year. (Nik Blaskovich)

Procore announces second recent acquisition

Read More →